Related Experiment Videos
Pharmacokinetic profiles and temporal changes in quantitative EEG after imipramine administrations
The Japanese Journal of Psychiatry and Neurology
|March 1, 1987
Summary
Quantitative electroencephalography (EEG) changes after imipramine treatment correlate with patient outcomes. Chronological EEG recordings can predict the prognosis for depressive patients receiving imipramine.
Area of Science:
- Neuroscience
- Psychopharmacology
- Clinical Neurophysiology
Background:
- Imipramine is a widely used antidepressant.
- Understanding the relationship between imipramine's pharmacokinetics and its effects on brain activity is crucial for optimizing treatment.
- Quantitative electroencephalography (qEEG) offers a method to objectively measure brain activity changes.
Purpose of the Study:
- To investigate the relationship between pharmacokinetic profiles of imipramine and temporal changes in quantitative EEG (qEEG).
- To determine if qEEG can predict clinical outcomes in patients with depression treated with imipramine.
Main Methods:
- Healthy subjects received single doses of imipramine via different routes.
- Depressive patients received single or multiple doses of imipramine orally or intramuscularly.
- Quantitative EEG (qEEG) was used to measure changes in alpha-power spectra.
- Plasma levels and pharmacokinetic parameters were monitored.
Main Results:
- A single dose of imipramine decreased alpha-power spectra in healthy subjects.
- EEG changes were time-dependent and related to pharmacokinetic parameters, not plasma levels.
- Imipramine, not its metabolite desipramine, mediated these effects.
- Depressive patients showed two types of EEG responses; Type 1 patients improved rapidly.
Conclusions:
- Chronological qEEG recordings can be valuable for predicting the clinical prognosis of depressive patients undergoing imipramine treatment.
- At a steady state, neither EEG recordings nor plasma level evaluation alone is sufficient for prognosis assessment.